Medical Properties Trust, Inc. (NYSE:MPW) Insider Sells $1,837,000.00 in Stock

Medical Properties Trust, Inc. (NYSE:MPW) insider Emmett E. Mclean sold 100,000 shares of the firm’s stock in a transaction that occurred on Monday, August 19th. The shares were sold at an average price of $18.37, for a total transaction of $1,837,000.00. Following the completion of the transaction, the insider now directly owns 1,066,337 shares of the company’s stock, valued at approximately $19,588,610.69. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Shares of MPW traded up $0.15 during midday trading on Monday, reaching $18.30. The stock had a trading volume of 1,690,400 shares, compared to its average volume of 3,819,141. Medical Properties Trust, Inc. has a 1-year low of $13.98 and a 1-year high of $18.92. The company’s fifty day simple moving average is $17.96 and its two-hundred day simple moving average is $18.09. The company has a market cap of $8.10 billion, a price-to-earnings ratio of 13.36, a PEG ratio of 3.35 and a beta of 0.60. The company has a debt-to-equity ratio of 0.99, a current ratio of 8.00 and a quick ratio of 9.37.

Medical Properties Trust (NYSE:MPW) last announced its quarterly earnings data on Thursday, August 1st. The real estate investment trust reported $0.31 earnings per share for the quarter, meeting the Zacks’ consensus estimate of $0.31. Medical Properties Trust had a net margin of 129.20% and a return on equity of 6.84%. The business had revenue of $192.55 million for the quarter, compared to analyst estimates of $186.11 million. During the same period last year, the business earned $0.36 EPS. The company’s revenue was down 4.6% on a year-over-year basis. On average, sell-side analysts forecast that Medical Properties Trust, Inc. will post 1.32 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Thursday, October 10th. Investors of record on Thursday, September 12th will be paid a dividend of $0.26 per share. This is a positive change from Medical Properties Trust’s previous quarterly dividend of $0.25. This represents a $1.04 annualized dividend and a yield of 5.68%. The ex-dividend date of this dividend is Wednesday, September 11th. Medical Properties Trust’s dividend payout ratio (DPR) is currently 72.99%.

A number of large investors have recently made changes to their positions in MPW. Vanguard Group Inc. raised its stake in Medical Properties Trust by 4.4% during the 2nd quarter. Vanguard Group Inc. now owns 59,568,283 shares of the real estate investment trust’s stock worth $1,038,870,000 after acquiring an additional 2,531,875 shares in the last quarter. Robeco Institutional Asset Management B.V. raised its stake in Medical Properties Trust by 2,802.9% during the 1st quarter. Robeco Institutional Asset Management B.V. now owns 1,523,055 shares of the real estate investment trust’s stock worth $28,192,000 after acquiring an additional 1,470,589 shares in the last quarter. BlackRock Inc. raised its stake in Medical Properties Trust by 3.4% during the 1st quarter. BlackRock Inc. now owns 44,368,188 shares of the real estate investment trust’s stock worth $821,255,000 after acquiring an additional 1,459,646 shares in the last quarter. Bank of America Corp DE raised its stake in Medical Properties Trust by 33.1% during the 2nd quarter. Bank of America Corp DE now owns 5,779,755 shares of the real estate investment trust’s stock worth $100,799,000 after acquiring an additional 1,438,268 shares in the last quarter. Finally, Panagora Asset Management Inc. raised its stake in Medical Properties Trust by 1,670.8% during the 2nd quarter. Panagora Asset Management Inc. now owns 1,461,703 shares of the real estate investment trust’s stock worth $25,492,000 after acquiring an additional 1,379,158 shares in the last quarter. Hedge funds and other institutional investors own 70.05% of the company’s stock.

MPW has been the topic of a number of analyst reports. SunTrust Banks upgraded shares of Medical Properties Trust from a “hold” rating to a “buy” rating and raised their price objective for the company from $19.00 to $20.00 in a report on Tuesday, July 2nd. Deutsche Bank upgraded shares of Medical Properties Trust from a “hold” rating to a “buy” rating in a report on Monday, July 29th. Zacks Investment Research lowered shares of Medical Properties Trust from a “hold” rating to a “sell” rating in a report on Wednesday, July 17th. Stifel Nicolaus set a $21.00 price objective on shares of Medical Properties Trust and gave the company a “buy” rating in a report on Monday, August 12th. Finally, ValuEngine lowered shares of Medical Properties Trust from a “buy” rating to a “hold” rating in a report on Thursday, August 1st. One investment analyst has rated the stock with a sell rating, three have given a hold rating and six have given a buy rating to the company. The company currently has a consensus rating of “Buy” and an average target price of $18.94.

Medical Properties Trust Company Profile

Medical Properties Trust, Inc is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT's financing model helps facilitate acquisitions and recapitalizations and allows operators of hospitals and other healthcare facilities to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.

See Also: What is the definition of a trade war?

Insider Buying and Selling by Quarter for Medical Properties Trust (NYSE:MPW)

Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.